🔥🐔 BizChicken 🐔🔥
Companies Similar to Exact Sciences Corporation
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Co-Diagnostics, Inc.
PCR diagnostic tests
Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect nucleic acid molecules, offering PCR tests for various diseases including COVID-19 and providing molecular diagnostic tools for healthcare and agricultural applications.
Symbol: CODX
Recent Price: $0.70
Industry: Medical - Devices
CEO: Mr. Dwight H. Egan
Sector: Healthcare
Employees: 155
Address: 2401 South Foothill Drive, Salt Lake City, UT 84109
Phone: 801 438 1036
Last updated: 2024-12-31
Lucid Diagnostics Inc.
Eso Guard, Eso Check
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company focused on detecting esophageal precancer in patients with gastroesophageal reflux disease.
About | Leadership | Contact | Careers | Careers | About | About | About | About | About | Careers
Symbol: LUCD
Recent Price: $0.80
Industry: Medical - Devices
CEO: Dr. Lishan Aklog M.D.
Sector: Healthcare
Employees: 70
Address: One Grand Central Place, New York, NY 10165
Phone: 212 949 4319
Leadership
- Lishan Aklog, MD, Chairman, Chief Executive Officer
- Shaun O'Neil, MBA, President & Chief Operating Officer
- Dennis McGrath, Chief Financial Officer
- Michael Gordon, General Counsel & Corporate Secretary
- Suman M. Verma, MD, PhD, Chief Scientific Officer
- Victoria T. Lee, MD, Chief Medical Officer
- Brian deGuzman, MD, Chief Technology & Compliance Officer
- Deepika A. Lakhani, PhD, Chief Regulatory & Quality Officer
- Stanley N. Lapidus, Vice-Chairman
- James L. Cox, MD, Board Member
- Dennis Matheis, Board Member
- Jacque J. Sokolov, MD, Board Member
- Ron Sparks, Board Member
- Debbie White, Board Member
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
Exponent, Inc.
Science and Engineering Consulting
Exponent, Inc. operates as a science and engineering consulting company offering services in Engineering and Other Scientific, and Environmental and Health segments. It provides solutions across various technical disciplines, including biomedical engineering, civil engineering, environmental sciences, and many more to address complex client challenges.
Symbol: EXPO
Recent Price: $88.94
Industry: Consulting Services
CEO: Dr. Catherine Ford Corrigan P.E., Ph.D.
Sector: Industrials
Employees: 949
Address: 149 Commonwealth Drive, Menlo Park, CA 94025
Phone: 650 326 9400
Last updated: 2024-12-31
Codexis, Inc.
Code Evolver
Codexis, Inc. discovers, develops, and sells enzymes and other proteins, offering biocatalyst products, services, and advanced protein engineering technology.
Symbol: CDXS
Recent Price: $4.67
Industry: Biotechnology
CEO: Dr. Stephen George Dilly MBBS, Ph.D.
Sector: Healthcare
Employees: 174
Address: 200 Penobscot Drive, Redwood City, CA 94063
Phone: 650 421 8100
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Exact Sciences Corporation
Cologuard
Exact Sciences Corporation provides cancer screening and diagnostic test products, including the non-invasive Cologuard test for colorectal cancer, Oncotype DX gene expression tests, and other specialized cancer diagnostics.
About | Leadership | History | DEI | About | Contact | Careers | Jobs | Careers | Careers | About | Careers | Careers | Careers | Careers | Locations | Benefits | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: EXAS
Recent Price: $56.20
Industry: Medical - Diagnostics & Research
CEO: Mr. Kevin T. Conroy
Sector: Healthcare
Employees: 6500
Address: 5505 Endeavor Lane, Madison, WI 53719
Phone: 608 284 5700
Leadership
- Kevin Conroy, Chairman and CEO
- Aaron Bloomer, Executive Vice President, Finance
- Sarah Condella, Executive Vice President, Human Resources
- Brian Baranick, Executive Vice President, General Manager, Precision Oncology
- Jake Orville, Executive Vice President, General Manager, Screening
- Dirk Zimmermann, General Manager, International
- Ana Hooker, Chief Laboratory Officer
- Veronica Descotte, Senior Vice President, Chief Strategy Officer
- Nassar Nizami, Chief Information Officer
- James Herriott, Senior Vice President, General Counsel and Secretary
- Jorge Garces, Chief Science Officer
- Morry Smulevitz, Senior Vice President, Corporate Affairs
- Graham Lidgard, Chief Science Officer, Emeritus
- Rick Baehner, Chief Medical Officer, Precision Oncology
- Tomasz Beer, Chief Medical Officer, Multi-Cancer Early Detection
- Steven Bellamy, Chief Medical Officer, International
- Paul Limburg, Chief Medical Officer, Screening
- Daniel Levangie, Governor
- James E. Doyle, Director
- Katherine S. Zanotti, Secretary
- Kathleen Sebelius, Director
- Mike Barber, Director
- Paul Clancy, Director
- Scott Coward, Director
- Shacey Petrovic, Director
Last updated: 2024-12-31
Fresh2 Group Limited
Multi-cancer screening and detection tests
Fresh2 Group Limited is a biotechnology company specializing in cancer screening and detection technologies, offering products and services such as genetic testing kits, skin-care products, and technology services in China. It also operates an e-commerce platform for food supply connections.
Symbol: FRES
Recent Price: $1.08
Industry: Biotechnology
CEO: Mr. Haohan Xu
Sector: Healthcare
Employees: 75
Address: 650 5th Ave, New York, NY 10019-6108
Phone: N/A
Last updated: 2024-11-08
IDEXX Laboratories, Inc.
N/A
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.
About | About | Contact | About | Locations | About | About | About | Foundation | News | ESG | Locations | About | About | About | About | About | About | Locations | About | About | About | About | About | About | About | Contact | Contact | Contact | Contact | Contact | Contact | Jobs | Careers | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | About | Culture | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About
Symbol: IDXX
Recent Price: $412.75
Industry: Medical - Diagnostics & Research
CEO: Mr. Jonathan J. Mazelsky
Sector: Healthcare
Employees: 11000
Address: One IDEXX Drive, Westbrook, ME 04092
Phone: 207 556 0300
Last updated: 2024-12-31
Myriad Genetics, Inc.
My Risk Hereditary Cancer Test
Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes genetic tests for oncology, women's health, and mental health applications.
Symbol: MYGN
Recent Price: $13.63
Industry: Medical - Diagnostics & Research
CEO: Mr. Paul J. Diaz
Sector: Healthcare
Employees: 2700
Address: 320 Wakara Way, Salt Lake City, UT 84108
Phone: 801 584 3600
Last updated: 2024-12-31
NeoGenomics, Inc.
Cancer-focused testing services
Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.
About | About | Leadership | Benefits | About | About | About | About | About | About | Contact | About | About | About
Symbol: NEO
Recent Price: $16.92
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher Michael Smith BSc
Sector: Healthcare
Employees: 2100
Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
Phone: 239 768 0600
Leadership
- Chris Smith, Chief Executive Officer
- Jeff Sherman, Chief Financial Officer
- Warren Stone, Chief Commercial Officer
- Melody Harris, Chief Operations Officer & President, Informatics
- Ali Olivo, Executive Vice President, General Counsel & Business Development
- Hutan Hashemi, JD, Chief Compliance Officer
- Nathan Montgomery, MD, PhD, Vice President, Medical Services
- Gary Passman, Chief Culture Officer
- Kareem Saad, Head of Strategy and Transformation
- Lynn A. Tetrault, Chair of the Board
- Bruce K. Crowther, Board Member
- Elizabeth Floegel, Board Member
- Neil Gunn, Board Member
- Alison L. Hannah, MD, Board Member
- Stephen Kanovsky, Board Member
- Michael A. Kelly, Board Member
- David Perez, Board Member
- Tony Zook, Board Member
- Derek Lyle, MD, Chief Medical Officer
- Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
- J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
- Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
- Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
- Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
- Renuka Agrawal, MD, Senior Hematopathologist
- Todd S. Barry, MD PhD, Senior Hematopathologist
- Bora Baysal, MD, PhD, Senior Hematopathologist
- Saskia Boisot, MD, Senior Hematopathologist
- Wayne W. Chen, MD PhD, Director of Hematopathology Services
- Rachel Flamholz, MD, Senior Hematopathologist
- Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
- Anselm Hii, MD, Director of Hematopathology Services
- Thanh Ho, MD, Senior Hematopathologist
- Kim Janatpour, MD MA, Senior Hematopathologist
- Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
- Sameer S. Khatri, MD, Hematopathologist
- Madeleine Kraus, MD, Senior Hematopathologist
- Brian Kwok, MD FCAP, Corporate Director of Hematopathology
- Keming Lin, MD MS FCAP, Senior Hematopathologist
- Robert Lin, MD, Senior Hematopathologist
- Russell L. Maiese, M.D., Senior Hematopathologist
- Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
- Viera Nelson, MD, Senior Hematopathologist
- Dennis P. O’Malley, MD, Senior Hematopathologist
- Anthony Padula, MD, Senior Hematopathologist
- Munir Shahjahan, MD MPH, Senior Hematopathologist
- Jesalyn J. Taylor, MD, Senior Hematopathologist
- Jian-Feng Wang, MD PhD, Senior Hematopathologist
- Zhao Wu, MD PhD FCAP, Senior Hematopathologist
- Aine Yung, MD FCAP, Senior Hematopathologist
- Sadiq Zaman, MD, Senior Hematopathologist
- Guohua Zhao, MD PhD, Senior Hematopathologist
- Mitual Amin, MD, Senior Surgical Pathologist
- Jerry Chu, MD PhD, Senior Surgical Pathologist
- Ted Farzaneh, MD, Senior Surgical Pathologist
- Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
- Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
- Robert Schwartz, MD, Senior Surgical Pathologist
- Yae K (Kay) Suh, MD, Senior Surgical Pathologist
- Matthew Geller, DO, Molecular Pathologist
- Hao Ho, MD, Molecular Pathologist
- Jennifer Hummel, MD, Senior Molecular Pathologist
- Armen Kaysan, MD, Molecular Pathologist
- Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
- Saed Sadeghi, MD, Molecular Pathologist
- Ying Wang, MD PhD, Molecular Pathologist
- Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
- Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
- Indu Gupta, MD, Surgical Pathologist, Pharma Services
- Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
- Albert Ho, Director of Pharma Pathology Services
- Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
- Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
- Li Cheng, PhD FACMG, Associate Director of Cytogenetics
- Liang Dong, MD PhD, Director of Cytogenetic Services
- Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
- Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
- Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
- John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
- Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
- Farzad Nooraie, MD, Director of Cytogenetic Services
- Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
- Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
- Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
- Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
- Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
- Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
- John N. Allan, MD, Scientific Advisory Board Member
- Rafael Bejar, MD, PhD, Scientific Advisory Board Member
- James R. Berenson, MD, Scientific Advisory Board Member
- Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
- James Downing, MD, Scientific Advisory Board Member
- Bernard A Fox, PhD, Scientific Advisory Board Member
- Gregory Hess, MD, Scientific Advisory Board Member
- Hatim Husain, MD, Scientific Advisory Board Member
- Tibor Kovacsovics, MD, Scientific Advisory Board Member
- Razelle Kurzrock, MD, Scientific Advisory Board Member
- Gail J. Roboz, MD, Scientific Advisory Board Member
- Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
- Mark A. Rubin, MD, Scientific Advisory Board Member
Last updated: 2024-12-31
OncoCyte Corporation
Determa Rx
Onco Cyte Corporation, based in Irvine, California, develops and commercializes molecular diagnostics tests for cancer detection, including Determa Rx and Determa IO.
Symbol: OCX
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Joshua Riggs
Sector: Healthcare
Employees: 43
Address: 15 Cushing, Irvine, CA 92618
Phone: 949 409 7600
Leadership
- Josh Riggs, President & Chief Executive Officer
- Prof. Dr. Ekkehard Schütz, MD, PhD, FAACC, Chief Science Officer
- Yuh-Min (Johnson) Chiang, PhD, Chief Technology Officer
- Andrea James, Chief Financial Officer
- Sandra O’Donald, Senior Vice President, Business Operations
- Ryan Andrews, Vice President, Commercial
- Peter Hong, Vice President, General Counsel
- James Liu, Senior Director, Controller & Principal Accounting Officer
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 O’Brien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
10x Genomics, Inc.
chromium instruments
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems globally. Their products include chromium instruments and single cell solutions for gene expression and immune profiling.
About | Contact | Contact | Contact | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: TXG
Recent Price: $14.35
Industry: Medical - Healthcare Information Services
CEO: Dr. Serge Saxonov Ph.D.
Sector: Healthcare
Employees: 1259
Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260
Phone: 925 401 7300
Last updated: 2024-12-31
Veracyte, Inc.
Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test
Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.
Symbol: VCYT
Recent Price: $40.00
Industry: Biotechnology
CEO: Mr. Marc A. Stapley
Sector: Healthcare
Employees: 815
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 243 6300
Last updated: 2024-12-31
Quest Diagnostics Incorporated
Diagnostic Information Services
Quest Diagnostics Incorporated offers a range of diagnostic testing and information services, including routine and advanced clinical testing, anatomic pathology, and risk assessment services for the life insurance industry, supported by a global network of laboratories and service professionals.
About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | DEI | About | About | Locations | About | About | About | About | About | Contact | Contact | Jobs | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Careers | Culture | Benefits | Events | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Site Map | Management | Careers | Jobs | Jobs | Jobs
Symbol: DGX
Recent Price: $150.97
Industry: Medical - Diagnostics & Research
CEO: Mr. James E. Davis
Sector: Healthcare
Employees: 50000
Address: 500 Plaza Drive, Secaucus, NJ 07094
Phone: 973 520 2700
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31